Deceptive claims barred for alleged cancer products – CHD

Worth noting if you or someone you love is chasing ‘alternative’ cures for cancer.

In response to a complaint for permanent injunction and other equitable relief by the Federal Trade Commission (FTC), Derek E. Vest, individually and as owner of CellMark Biopharma, LLC, has signed a stipulated order for permanent injunction that prohibits the company from making any representation for any dietary supplement, food, or drug of treating, curing, mitigating, or preventing any disease; symptom of cancer; and side effect, condition, or ailment resulting from cancer treatment. The FTC’s complaint alleged deceptive advertising of two CellMark products: (1) CellAssure, which was marketed as having “anti-cancer and anti-tumor properties” and as a medical breakthrough solution for cancer-related malnutrition; and (2) Cognify, which the company promoted for patients receiving chemotherapy as “the world’s first product designed specifically to alleviate…chemo fog.” [Marketers barred from making deceptive claims about products’ ability to mitigate side effects of cancer treatment: CellMark and its CEO lacked scientific evidence to back up their products’ claims. FTC news release, Jan 11, 2018]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s